In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d.
Publication
, Journal Article
Greenblatt, LH
Published in: Ann Intern Med
January 2023
Hsia J, Guthrie NL, Lupinacci P, et al. Randomized, controlled trial of a digital behavioral therapeutic application to improve glycemic control in adults with type 2 diabetes. Diabetes Care. 2022;45:2976-81. 36181554.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 2023
Volume
176
Issue
1
Start / End Page
JC10
Location
United States
Related Subject Headings
- Mobile Applications
- Humans
- General & Internal Medicine
- Diabetes Mellitus, Type 2
- Adult
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Greenblatt, L. H. (2023). In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d. Ann Intern Med, 176(1), JC10. https://doi.org/10.7326/J22-0109
Greenblatt, Lawrence H. “In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d.” Ann Intern Med 176, no. 1 (January 2023): JC10. https://doi.org/10.7326/J22-0109.
Greenblatt LH. In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d. Ann Intern Med. 2023 Jan;176(1):JC10.
Greenblatt, Lawrence H. “In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d.” Ann Intern Med, vol. 176, no. 1, Jan. 2023, p. JC10. Pubmed, doi:10.7326/J22-0109.
Greenblatt LH. In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d. Ann Intern Med. 2023 Jan;176(1):JC10.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 2023
Volume
176
Issue
1
Start / End Page
JC10
Location
United States
Related Subject Headings
- Mobile Applications
- Humans
- General & Internal Medicine
- Diabetes Mellitus, Type 2
- Adult
- 3202 Clinical sciences
- 11 Medical and Health Sciences